Grandfield & Dodd’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.71M | Sell |
7,691
-485
| -6% | -$173K | 0.15% | 72 |
|
|
2025
Q4 | $2.68M | Hold |
8,176
| – | – | 0.15% | 73 |
|
|
2025
Q3 | $2.31M | Hold |
8,176
| – | – | 0.13% | 81 |
|
|
2025
Q2 | $2.28M | Buy |
8,176
+158
| +2% | +$44.8K | 0.13% | 78 |
|
|
2025
Q1 | $2.5M | Hold |
8,018
| – | – | 0.15% | 76 |
|
|
2024
Q4 | $2.09M | Sell |
8,018
-275
| -3% | -$81.6K | 0.13% | 80 |
|
|
2024
Q3 | $2.67M | Sell |
8,293
-525
| -6% | -$172K | 0.16% | 74 |
|
|
2024
Q2 | $2.76M | Hold |
8,818
| – | – | 0.17% | 71 |
|
|
2024
Q1 | $2.51M | Buy |
8,818
+5
| +0.1% | +$1.46K | 0.16% | 74 |
|
|
2023
Q4 | $2.54M | Sell |
8,813
-480
| -5% | -$131K | 0.18% | 71 |
|
|
2023
Q3 | $2.5M | Sell |
9,293
-100
| -1% | -$25K | 0.18% | 73 |
|
|
2023
Q2 | $2.09M | Sell |
9,393
-996
| -10% | -$231K | 0.15% | 76 |
|
|
2023
Q1 | $2.51M | Buy |
10,389
+770
| +8% | +$189K | 0.18% | 74 |
|
|
2022
Q4 | $2.53M | Sell |
9,619
-59
| -0.6% | -$15.8K | 0.18% | 72 |
|
|
2022
Q3 | $2.18M | Sell |
9,678
-701
| -7% | -$170K | 0.18% | 73 |
|
|
2022
Q2 | $2.53M | Sell |
10,379
-158
| -1% | -$38.7K | 0.2% | 71 |
|
|
2022
Q1 | $2.55M | Sell |
10,537
-450
| -4% | -$103K | 0.17% | 74 |
|
|
2021
Q4 | $2.47M | Sell |
10,987
-1,056
| -9% | -$223K | 0.16% | 73 |
|
|
2021
Q3 | $2.56M | Sell |
12,043
-1,169
| -9% | -$269K | 0.18% | 70 |
|
|
2021
Q2 | $3.22M | Sell |
13,212
-341
| -3% | -$83.9K | 0.22% | 66 |
|
|
2021
Q1 | $3.37M | Sell |
13,553
-172
| -1% | -$41K | 0.25% | 65 |
|
|
2020
Q4 | $3.16M | Sell |
13,725
-885
| -6% | -$204K | 0.25% | 66 |
|
|
2020
Q3 | $3.71M | Sell |
14,610
-718
| -5% | -$178K | 0.33% | 62 |
|
|
2020
Q2 | $3.62M | Sell |
15,328
-4,282
| -22% | -$977K | 0.35% | 59 |
|
|
2020
Q1 | $3.98M | Sell |
19,610
-10,070
| -34% | -$2.2M | 0.47% | 56 |
|
|
2019
Q4 | $7.16M | Sell |
29,680
-452
| -2% | -$99.6K | 0.65% | 50 |
|
|
2019
Q3 | $5.83M | Sell |
30,132
-627
| -2% | -$120K | 0.57% | 52 |
|
|
2019
Q2 | $5.67M | Sell |
30,759
-1,789
| -5% | -$320K | 0.56% | 51 |
|
|
2019
Q1 | $6.18M | Sell |
32,548
-690
| -2% | -$132K | 0.64% | 49 |
|
|
2018
Q4 | $6.47M | Sell |
33,238
-1,044
| -3% | -$204K | 0.77% | 48 |
|
|
2018
Q3 | $7.11M | Sell |
34,282
-1,492
| -4% | -$294K | 0.73% | 50 |
|
|
2018
Q2 | $6.6M | Sell |
35,774
-1,983
| -5% | -$351K | 0.73% | 47 |
|
|
2018
Q1 | $6.44M | Sell |
37,757
-1,162
| -3% | -$213K | 0.72% | 47 |
|
|
2017
Q4 | $6.77M | Sell |
38,919
-2,277
| -6% | -$403K | 0.72% | 47 |
|
|
2017
Q3 | $7.68M | Sell |
41,196
-7,821
| -16% | -$1.39M | 0.86% | 46 |
|
|
2017
Q2 | $8.44M | Sell |
49,017
-8,358
| -15% | -$1.36M | 1% | 41 |
|
|
2017
Q1 | $9.41M | Sell |
57,375
-4,411
| -7% | -$733K | 1.16% | 37 |
|
|
2016
Q4 | $9.03M | Sell |
61,786
-2,260
| -4% | -$340K | 1.17% | 36 |
|
|
2016
Q3 | $10.7M | Sell |
64,046
-3,885
| -6% | -$657K | 1.4% | 32 |
|
|
2016
Q2 | $10.3M | Sell |
67,931
-7,250
| -10% | -$1.13M | 1.45% | 30 |
|
|
2016
Q1 | $11.3M | Sell |
75,181
-7,288
| -9% | -$1.08M | 1.63% | 27 |
|
|
2015
Q4 | $13.4M | Sell |
82,469
-2,018
| -2% | -$317K | 2.03% | 14 |
|
|
2015
Q3 | $11.7M | Sell |
84,487
-1,450
| -2% | -$229K | 1.96% | 14 |
|
|
2015
Q2 | $13.2M | Sell |
85,937
-8,885
| -9% | -$1.42M | 2.02% | 11 |
|
|
2015
Q1 | $15.2M | Sell |
94,822
-250
| -0.3% | -$39.4K | 2.32% | 10 |
|
|
2014
Q4 | $15.1M | Sell |
95,072
-7,670
| -7% | -$1.2M | 2.34% | 11 |
|
|
2014
Q3 | $14.4M | Buy |
102,742
+970
| +1% | +$127K | 2.27% | 9 |
|
|
2014
Q2 | $12M | Buy |
101,772
+125
| +0.1% | +$14.5K | 1.82% | 19 |
|
|
2014
Q1 | $12.5M | Sell |
101,647
-1,385
| -1% | -$168K | 1.97% | 13 |
|
|
2013
Q4 | $11.8M | Sell |
103,032
-1,450
| -1% | -$165K | 1.91% | 14 |
|
|
2013
Q3 | $11.7M | Sell |
104,482
-1,175
| -1% | -$127K | 2.09% | 12 |
|
|
2013
Q2 | $10.4M | Buy |
+105,657
| New | +$11M | 1.97% | 14 |
|
Other funds holding AMGN
VCM
VPM
Grandfield & Dodd's AMGN Position: Q1 2026 in Review
Grandfield & Dodd reduced its Amgen (AMGN) stake by 5.9% in Q1 2026, selling an estimated $173K and leaving 7,691 shares worth $2.71M. The position accounts for 0.15% of the portfolio, ranked #72.
Grandfield & Dodd first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.2M in Q1 2015. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Grandfield & Dodd held 7,691 shares of Amgen worth $2.71M as of Q1 2026.
- Grandfield & Dodd sold 485 Amgen shares in Q1 2026, an estimated $173K.
- Amgen made up 0.15% of Grandfield & Dodd's portfolio in Q1 2026, its #72 holding.
- Grandfield & Dodd first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Grandfield & Dodd's Amgen position peaked at $15.2M in Q1 2015.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Grandfield & Dodd's 13F filing for Q1 2026, filed 7 May 2026.